The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
Face2Face Africa on MSN
Guinea-Bissau halts US-backed newborn hepatitis B trial over ethical concerns
Guinea-Bissau has put a halt to a U.S.-backed hepatitis B vaccine study involving newborns, pending a formal ethical ...
MedPage Today on MSN
Guinea-Bissau suspends Trump-backed Hep B vaccine trial for ethical review
But HHS spokesman says the study "is proceeding as planned" ...
IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...
A randomized crossover feeding trial in adults aged 65 years or older found that plant-forward diets incorporating either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback